SHH and colitis: To further confirm whether Shh pathway activation is involved in the protective effect of EDT on DSS-induced colitis, we used Cyc, a specific Smo receptor inhibitor, to inhibit Shh pathway activation and subsequently evaluated the effect of Cyc treatment on weight loss, DAI score, histological score and colon length.